J9316 Pertuzu, trastuzu, 10 milligrams
Also known as: pertuzumab trastuzumab, Perjeta Herceptin
Injection of pertuzumab combined with trastuzumab, 10 milligram total. Dual HER2-targeting antibody combination therapy.
In Plain Language
breast cancer combination injection; HER2 dual therapy
Clinical Context
Combined HER2-targeting therapy for metastatic breast cancer. Requires careful dosing and monitoring for cardiac dysfunction.
RVU Information
CPT J9316 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9316?
CPT J9316 (Pertuzu, trastuzu, 10 milligrams) is a J Codes (Drugs) code. Injection of pertuzumab combined with trastuzumab, 10 milligram total. Dual HER2-targeting antibody combination therapy.
How is J9316 administered?
CPT J9316 is administered by a healthcare provider, typically via injection or infusion. Combined HER2-targeting therapy for metastatic breast cancer. Requires careful dosing and monitoring for cardiac dysfunction. It is used by Oncology, Surgery, Cardio-oncology.
When is CPT J9316 used?
Combined HER2-targeting therapy for metastatic breast cancer. Requires careful dosing and monitoring for cardiac dysfunction.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.